These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 22743060

  • 1. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
    Bot I, de Vries H, Korporaal SJ, Foks AC, Bot M, van Veldhoven J, Ter Borg MN, van Santbrink PJ, van Berkel TJ, Kuiper J, Ijzerman AP.
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
    [Abstract] [Full Text] [Related]

  • 2. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y, Hu Z, Ye J, Hu C, Song Q, Da X, Yu Y, Li H, Xu C, Chen Q, Wang QK.
    J Am Heart Assoc; 2017 Jun 25; 6(6):. PubMed ID: 28649088
    [Abstract] [Full Text] [Related]

  • 3. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL, Gao CY, Fang CQ, Wang YJ, Gao D, Yao GE, Xiang J, Wang JZ, Li JC.
    Cardiovasc Res; 2011 Dec 01; 92(3):484-93. PubMed ID: 21880694
    [Abstract] [Full Text] [Related]

  • 4. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
    Shagdarsuren E, Bidzhekov K, Mause SF, Simsekyilmaz S, Polakowski T, Hawlisch H, Gessner JE, Zernecke A, Weber C.
    Circulation; 2010 Sep 07; 122(10):1026-36. PubMed ID: 20733098
    [Abstract] [Full Text] [Related]

  • 5. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A, Zernecke A, Liehn EA, von Hundelshausen P, Knarren S, Kuziel WA, Weber C.
    Circ Res; 2004 Nov 26; 95(11):1125-33. PubMed ID: 15528472
    [Abstract] [Full Text] [Related]

  • 6. Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β.
    Talasila A, Yu H, Ackers-Johnson M, Bot M, van Berkel T, Bennett MR, Bot I, Sinha S.
    Arterioscler Thromb Vasc Biol; 2013 Oct 26; 33(10):2355-65. PubMed ID: 23825366
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
    Chen J, Zhang J, Xu L, Xu C, Chen S, Yang J, Jiang H.
    Atherosclerosis; 2012 Oct 26; 224(2):332-9. PubMed ID: 22857898
    [Abstract] [Full Text] [Related]

  • 8. Cigarette smoke exposure promotes arterial thrombosis and vessel remodeling after vascular injury in apolipoprotein E-deficient mice.
    Schroeter MR, Sawalich M, Humboldt T, Leifheit M, Meurrens K, Berges A, Xu H, Lebrun S, Wallerath T, Konstantinides S, Schleef R, Schaefer K.
    J Vasc Res; 2008 Oct 26; 45(6):480-92. PubMed ID: 18434747
    [Abstract] [Full Text] [Related]

  • 9. Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice.
    Karshovska E, Zernecke A, Sevilmis G, Millet A, Hristov M, Cohen CD, Schmid H, Krotz F, Sohn HY, Klauss V, Weber C, Schober A.
    Arterioscler Thromb Vasc Biol; 2007 Dec 26; 27(12):2540-7. PubMed ID: 17932320
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice.
    Schober A, Knarren S, Lietz M, Lin EA, Weber C.
    Circulation; 2003 Nov 18; 108(20):2491-7. PubMed ID: 14581398
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
    Duran-Prado M, Morell M, Delgado-Maroto V, Castaño JP, Aneiros-Fernandez J, de Lecea L, Culler MD, Hernandez-Cortes P, O'Valle F, Delgado M.
    Circ Res; 2013 May 24; 112(11):1444-55. PubMed ID: 23595952
    [Abstract] [Full Text] [Related]

  • 15. BubR1 insufficiency inhibits neointimal hyperplasia through impaired vascular smooth muscle cell proliferation in mice.
    Kyuragi R, Matsumoto T, Harada Y, Saito S, Onimaru M, Nakatsu Y, Tsuzuki T, Nomura M, Yonemitsu Y, Maehara Y.
    Arterioscler Thromb Vasc Biol; 2015 Feb 24; 35(2):341-7. PubMed ID: 25524773
    [Abstract] [Full Text] [Related]

  • 16. Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
    Hlawaty H, Jacob MP, Louedec L, Letourneur D, Brink C, Michel JB, Feldman L, Bäck M.
    Arterioscler Thromb Vasc Biol; 2009 Apr 24; 29(4):518-24. PubMed ID: 19164806
    [Abstract] [Full Text] [Related]

  • 17. Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury.
    Kapopara PR, von Felden J, Soehnlein O, Wang Y, Napp LC, Sonnenschein K, Wollert KC, Schieffer B, Gaestel M, Bauersachs J, Bavendiek U.
    Thromb Haemost; 2014 Dec 24; 112(6):1264-76. PubMed ID: 25120198
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human urine kininogenase attenuates balloon-induced intimal hyperplasia in rabbit carotid artery through transforming growth factor β1/Smad2/3 signaling pathway.
    Lan W, Yang F, Li Z, Liu L, Sang H, Jiang Y, Xiong Y, Zhang R.
    J Vasc Surg; 2016 Oct 24; 64(4):1074-83. PubMed ID: 26054589
    [Abstract] [Full Text] [Related]

  • 20. Adenosine, Via A2B Receptors, Inhibits Human (P-SMC) Progenitor Smooth Muscle Cell Growth.
    Dubey RK, Baruscotti I, Stiller R, Fingerle J, Gillespie DG, Mi Z, Leeners B, Imthurn B, Rosselli M, Jackson EK.
    Hypertension; 2020 Jan 24; 75(1):109-118. PubMed ID: 31786976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.